JPMorgan prices $325K capped notes linked to DJIA
JPMorgan Chase Financial Company LLC priced $325,000 of capped dual directional buffered equity notes linked to the Dow Jones Industrial Average®.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
JPMorgan Chase Financial Company LLC priced $325,000 of capped dual directional buffered equity notes linked to the Dow Jones Industrial Average®. The notes priced on March 6, 2026 with expected settlement on or about March 11, 2026 and mature on April 9, 2027 (observation date April 6, 2027).
Per note, the structure offers a Maximum Upside Return of 8.40%, a Buffer Amount of 10.00% and an inverse capped payoff on declines (up to a 90.00% principal loss if the Index falls more than the buffer). The Initial Value was 47,501.55. Price to public was $1,000 per note, estimated value was $975.90, and listed selling commissions reduce proceeds to the issuer to $993.2115 per note.
Insights
These are principal-at-risk notes with symmetrical capped payoffs and a 10% downside buffer.
The notes provide capped upside of 8.40% if the Dow rises and a buffered absolute-decline payoff up to the 10.00% Buffer Amount; beyond that buffer, losses reduce principal dollar-for-dollar. The Initial Value was 47,501.55 as of the Pricing Date.
Secondary market liquidity is limited and repurchase pricing may be below issue price; cash-flow exposure is to JPMorgan Financial and guaranteed by JPMorgan Chase & Co., so credit risk of both entities matters.
Tax treatment is uncertain; issuer intends "open transaction" characterization.
The issuer intends to treat the notes as open transactions for U.S. federal income tax purposes, which would generally yield long-term capital gain or loss if held over a year. This position is based on counsel advice but is not binding on the IRS.
Alternative treatments (e.g., contingent payment debt instrument) could change timing and character of income; purchasers should consult tax advisers regarding potential alternatives and Section 871(m) considerations for Non-U.S. Holders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is being offered in the AMJB pricing supplement?
How are returns calculated for AMJB notes at maturity?
What downside protection and maximum loss does AMJB provide?
Who bears credit risk for the AMJB notes?
What were the per-note pricing details for AMJB?
AI-generated analysis. How Rhea-AI works. Not financial advice.